|Articles|October 14, 2022
- Applied Clinical Trials-10-01-2022
- Volume 31
- Issue 10
Applied Clinical Trials October 2022 Issue (PDF)
Click the title above for a link to open the Applied Clinical Trials October 2022 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 3 years ago
Managing Biospecimens in Cell and Gene Therapy Trialsabout 3 years ago
The Risk-Reward Proposition for CGT Clinical Trialsabout 3 years ago
Philadelphia Shines in Cell and Gene Therapy Research Pursuitsabout 3 years ago
Survey Investigates Backup Solution Adoption for ePRO Systemsabout 3 years ago
Scientists Don’t Ever Stop Sciencingabout 3 years ago
Key Clinical Trial Industry Themes Post-COVIDNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: AI, Equity, and Innovation Drive Clinical Research Forward
2
Reducing Site Burden Through Better Technology Integration in Clinical Trials
3
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
4
Broad Survival Benefit from MATTERHORN Trial Highlights New Approach to Biomarker Use
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
